These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20826196)

  • 1. β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration.
    Caušević M; Farooq U; Lovestone S; Killick R
    Neurosci Lett; 2010 Nov; 485(3):162-6. PubMed ID: 20826196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.
    Elliott E; Laufer O; Ginzburg I
    J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
    Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
    Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
    Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
    Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain.
    Beeson JG; Shelton ER; Chan HW; Gage FH
    J Comp Neurol; 1994 Apr; 342(1):69-77. PubMed ID: 8207128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.
    Löffler KU; Edward DP; Tso MO
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):24-31. PubMed ID: 7822152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
    Terwel D; Dewachter I; Van Leuven F
    Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease.
    Brohede J; Rinde M; Winblad B; Graff C
    J Neurogenet; 2010 Dec; 24(4):179-81. PubMed ID: 20919856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats.
    Lin L; Yang SS; Chu J; Wang L; Ning LN; Zhang T; Jiang Q; Tian Q; Wang JZ
    J Alzheimers Dis; 2014; 41(4):1149-63. PubMed ID: 24787918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.